JOHN YOO is listed as a director on 6 SEC Form D filings by 1 issuer between May 2016 and May 2018: Cotinga Pharmaceuticals Inc. (London, Ontario, Canada (as filed: A6) — biotechnology — 2016–2018; $1.58M reported sold to 6 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside ALISON D SILVA (6 shared filings), DAVID SANDERSON (6 shared filings), DOUGLAS S ALEXANDER (6 shared filings), GENE KELLY (6 shared filings), JOHN C DRAKE (6 shared filings) and 3 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around JOHN. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 6 bankruptcy cases matching the name listed in Key records below.
What this means 6 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 6 public filings for JOHN YOO and found 6 differences, 1 worth asking the sponsor about: Form D filed 434 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.